Evidence map›Paper›PMID 35059422›Full record

ArticleFrontiers in medicine2021

Identification and Validation of Novel Serum Autoantibodies Biomarkers for Staging Liver Fibrosis in Patients With Chronic Hepatitis B.

Saiping Qi, Jing Li, Xiaomin He, Jialing Zhou, Zhibin Chen, Xiaojin Li, Bei Zhang, Hong Ma, Hong You, Jian Huang

Open access · goldAbstract read
In one paragraph

Article in Frontiers in medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 54% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. The Prevalence and Clinical Significance of the Centromere Protein-F-Like Immunofluorescence Staining Pattern in a Large ANA-positive Cohort.Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Saiping QiExperimental Center, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
Jing LiDepartment of Healthcare Medicine, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
Xiaomin HeExperimental Center, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
Jialing ZhouLiver Research Center, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
Zhibin ChenExperimental Center, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
Xiaojin LiExperimental Center, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
Bei ZhangExperimental Center, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
Hong MaLiver Research Center, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
Hong YouExperimental Center, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
Jian HuangExperimental Center, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
Capital Medical University · CNBeijing Friendship Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

autoantibodychronic hepatitis Bhepatic fibrosisserum biomarkerstage

Identifiers

PMID35059422
PMCPMC8764302
OpenAlexW4206655626

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.